144 related articles for article (PubMed ID: 33132024)
1. Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy.
Prabhu N; Kapur N; Catalona W; Leikin R; Helenowski I; Jovanovich B; Gurley M; Okwuosa TM; Kuzel TM
Urol Oncol; 2021 Feb; 39(2):130.e9-130.e15. PubMed ID: 33132024
[TBL] [Abstract][Full Text] [Related]
2. Preoperative statin therapy is not associated with biochemical recurrence after radical prostatectomy: our experience and meta-analysis.
Mass AY; Agalliu I; Laze J; Lepor H
J Urol; 2012 Sep; 188(3):786-91. PubMed ID: 22818136
[TBL] [Abstract][Full Text] [Related]
3. Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center study.
Cattarino S; Seisen T; Drouin SJ; Renard-Penna R; Leon P; Comperat E; Mozer P; Cussenot O; Rouprêt M
Can J Urol; 2015 Apr; 22(2):7703-8. PubMed ID: 25891333
[TBL] [Abstract][Full Text] [Related]
4. Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Allott EH; Howard LE; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Freedland SJ
BJU Int; 2014 Nov; 114(5):661-6. PubMed ID: 24588774
[TBL] [Abstract][Full Text] [Related]
5. Effect of statin use on biochemical outcome following radical prostatectomy.
Ritch CR; Hruby G; Badani KK; Benson MC; McKiernan JM
BJU Int; 2011 Oct; 108(8 Pt 2):E211-6. PubMed ID: 21453350
[TBL] [Abstract][Full Text] [Related]
6. Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.
Hamilton RJ; Banez LL; Aronson WJ; Terris MK; Platz EA; Kane CJ; Presti JC; Amling CL; Freedland SJ
Cancer; 2010 Jul; 116(14):3389-98. PubMed ID: 20586112
[TBL] [Abstract][Full Text] [Related]
7. Statin use after radical prostatectomy reduces biochemical recurrence in men with prostate cancer.
Song C; Park S; Park J; Shim M; Kim A; Jeong IG; Hong JH; Kim CS; Ahn H
Prostate; 2015 Feb; 75(2):211-7. PubMed ID: 25327522
[TBL] [Abstract][Full Text] [Related]
8. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
Chao C; Jacobsen SJ; Xu L; Wallner LP; Porter KR; Williams SG
BJU Int; 2013 May; 111(6):954-62. PubMed ID: 23464862
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Statin Use at the Time of Radical Prostatectomy Is Not Associated With Biochemical Recurrence or Pathologic Upgrading.
Lyon TD; Turner RM; Yabes JG; Woldemichael E; Davies BJ; Jacobs BL; Nelson JB
Urology; 2016 Nov; 97():153-159. PubMed ID: 27516122
[TBL] [Abstract][Full Text] [Related]
10. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
11. Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database.
Aminsharifi A; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Polascik TJ; Freedland SJ
Clin Genitourin Cancer; 2019 Feb; 17(1):e140-e149. PubMed ID: 30366879
[TBL] [Abstract][Full Text] [Related]
12. Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery.
Mondul AM; Han M; Humphreys EB; Meinhold CL; Walsh PC; Platz EA
J Urol; 2011 Apr; 185(4):1268-73. PubMed ID: 21334020
[TBL] [Abstract][Full Text] [Related]
13. [Is statin use associated with D'Amico risk groups and biochemical recurrence after radical prostatectomy?].
Misrai V; Do C; Lhez JM; Elman B; Latorzeff I; Portalez D; Grosclaude P
Prog Urol; 2012 May; 22(5):273-8. PubMed ID: 22515923
[TBL] [Abstract][Full Text] [Related]
14. Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer.
Ishak-Howard MB; Okoth LA; Cooney KA
Urology; 2014 Jun; 83(6):1356-61. PubMed ID: 24745796
[TBL] [Abstract][Full Text] [Related]
15. National Comprehensive Cancer Network (NCCN) risk classification in predicting biochemical recurrence after radical prostatectomy: a retrospective cohort study in Chinese prostate cancer patients.
Xu H; Zhu Y; Dai B; Ye DW
Asian J Androl; 2018; 20(6):551-554. PubMed ID: 30027928
[TBL] [Abstract][Full Text] [Related]
16. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
17. Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy.
Rieken M; Kluth LA; Xylinas E; Seitz C; Fajkovic H; Karakiewicz PI; Lotan Y; Briganti A; Loidl W; Faison T; Crivelli JJ; Scherr DS; Bachmann A; Tewari AK; Kautzky-Willer A; Pummer K; Shariat SF
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):367-71. PubMed ID: 23999669
[TBL] [Abstract][Full Text] [Related]
18. Assessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancer.
Nyame YA; Wilkins L; Greene DJ; Ganesan V; Dai C; Almassi N; Stephenson AJ; Gong M; Berglund R; Klein EA
Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):617-623. PubMed ID: 30996285
[TBL] [Abstract][Full Text] [Related]
19. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
[TBL] [Abstract][Full Text] [Related]
20. Men presenting for radical prostatectomy on preoperative statin therapy have reduced serum prostate specific antigen.
Krane LS; Kaul SA; Stricker HJ; Peabody JO; Menon M; Agarwal PK
J Urol; 2010 Jan; 183(1):118-24. PubMed ID: 19913252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
